Market Study on Molecular Diagnostics in Infectious Disease Testing: North America to Continue Leading Global Market Growth

Sep 2022| PMR2038A| Persistence Market Research

Report Highlights

Molecular Diagnostics in Infectious Disease Testing Market - Scope of Report

Persistence Market Research recently published a new report on the molecular diagnostics in infectious disease testing market for the assessment period of 2022-2032. The report offers a close look at the evolving aspects of the market, and insights into the dynamics impacting market growth. It also focuses on key developments in the market, especially due to the COVID-19 pandemic situation that has affected people, globally. The report includes various macro- and micro-economic factors responsible for a significant impact on market growth.

The report on the molecular diagnostics in infectious disease testing market extensively focuses on the key trends shaping its growth. Additionally, the included opportunity analysis underlines untapped corners for aspiring players. The report also offers a holistic view of the incremental opportunity, which can further help readers make effective decisions for the growth of their businesses.

All stakeholders in the molecular diagnostics in infectious disease testing market can rely on the data offered in this report to make critical decisions. Moreover, the information offered in this report also can help new market entrants expand their bases in this space.

The report elaborates on both, historical and current trends shaping the molecular diagnostics in infectious disease testing market. The performance journey of the market has been drawn and analyzed to make the lucrative opportunities in the market evident to readers. The competitive landscape presented in the report gives a detailed outlook of the profiles of key companies manufacturing molecular diagnostics in infectious disease testing, along with their differential strategies and key focus areas.

Segmentation

The research study offers a detailed market taxonomy, wherein, key segments have been discussed in detail. The market is segmented on the basis of product, application, technique, end user, and region. Every segment is analyzed in detail, and data pertaining to the growth of each segment has been included in the study.

Product

  • Instruments and Analyzers
  • Assays and Reagents
  • Services and Software

Application

  • Hepatitis B
  • Hepatitis C
  • AIDS
  • Tuberculosis
  • Methicillin-Resistant Staphylococcus Aureus (MRSA)
  • Hospital-Acquired Infections
  • Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
  • Human Papillomavirus (HPV) Infection
  • Others

Technique

  • Polymerase Chain Reaction (PCR)
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Microarrays
  • Next-Generation Sequencing (NGS)
  • Hybridization
  • Others

End User

  • Hospitals
  • Private Labs
  • Clinics
  • Academic Institutes
  • Laboratories
  • Others

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

The research report includes a competitive landscape that provides a dashboard view of the key competitors operating in the market. Some of the market players included in this section are Abbott Laboratories, Becton, Dickinson and Company, bioMérieux, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Siemens AG, Veridex, LLC, Luminex Corp., GenMark Diagnostics, Inc., Qiagen N.V., Genomix Biotech, and bioTheranostics.

Key Questions Answered in Report

The research study on the manufacturing molecular diagnostics in infectious disease testing market offers inclusive insights about the growth of the market in the most comprehensive manner. Key insights offered in the report answer some of the most salient questions that assist stakeholders in gauging all the emerging possibilities.

  • Will the polymerase chain reaction (PCR) segment continue driving the sales of molecular diagnostics in infectious disease testing market?
  • How are technological developments aiding molecular diagnostics in infectious disease testing market?
  • Which region is a key contributor to the global molecular diagnostics in infectious disease testing market?

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022-2032
Units considered $ Million
Segments covered Product, Application, Technique, End User, Region
Industry covered Healthcare
Countries covered North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East & Africa
Companies studied
Abbott Laboratories
Becton
Dickinson and Company
bioMérieux
Thermo Fisher Scientific Inc.
F. Hoffmann-La Roche Ltd
Siemens AG
Veridex, LLC
Luminex Corp.
GenMark Diagnostics, Inc.
Qiagen N.V.
Genomix Biotech
bioTheranostics

Research Methodology

A unique and promising research methodology forms the base of the market report for the forecast period. This report has been prepared after comprehensive analysis of market events, and riveting insights have been compiled meticulously.

The research methodology is a two-step process comprising primary and secondary research. Key stakeholders, including suppliers, service providers, and experts of several designations, including executive vice presidents, directors, technical advisors, GM marketing professionals, and sales professionals have been interviewed. Secondary sources referred to obtain information include investor presentations of manufacturers, World Bank, IMF, and other credible sources.

  • Table 1 : Global Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017–2032
  • Table 2 : Global Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Product, 2017–2032
  • Table 3 : Global Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017–2032
  • Table 4 : Global Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By End User, 2017–2032
  • Table 5 : Global Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017–2032
  • Table 6 : Global Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Application, 2017–2032
  • Table 7 : Global Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017–2032
  • Table 8 : Global Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Technique, 2017–2032
  • Table 9 : Global Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Region, 2017–2032
  • Table 10 : Global Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Region, 2017–2032
  • Table 11 : North America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Country, 2017–2032
  • Table 12 : North America Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Country, 2017–2032
  • Table 13 : North America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017–2032
  • Table 14 : North America Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Product, 2017–2032
  • Table 15 : North America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017–2032
  • Table 16 : North America Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By End User, 2017–2032
  • Table 17 : North America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017–2032
  • Table 18 : North America Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Application, 2017–2032
  • Table 19 : North America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017–2032
  • Table 20 : North America Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Technique, 2017–2032
  • Table 21 : Latin America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Country, 2017–2032
  • Table 22 : Latin America Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Country, 2017–2032
  • Table 23 : Latin America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017–2032
  • Table 24 : Latin America Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Product, 2017–2032
  • Table 25 : Latin America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017–2032
  • Table 26 : Latin America Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By End User, 2017–2032
  • Table 27 : Latin America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017–2032
  • Table 28 : Latin America Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Application, 2017–2032
  • Table 29 : Latin America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017–2032
  • Table 30 : Latin America Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Technique, 2017–2032
  • Table 31 : Europe Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Country, 2017–2032
  • Table 32 : Europe Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Country, 2017–2032
  • Table 33 : Europe Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017–2032
  • Table 34 : Europe Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Product, 2017–2032
  • Table 35 : Europe Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017–2032
  • Table 36 : Europe Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By End User, 2017–2032
  • Table 37 : Europe Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017–2032
  • Table 38 : Europe Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Application, 2017–2032
  • Table 39 : Europe Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017–2032
  • Table 40 : Europe Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Technique, 2017–2032
  • Table 41 : East Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Country, 2017–2032
  • Table 42 : East Asia Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Country, 2017–2032
  • Table 43 : East Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017–2032
  • Table 44 : East Asia Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Product, 2017–2032
  • Table 45 : East Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017–2032
  • Table 46 : East Asia Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By End User, 2017–2032
  • Table 47 : East Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017–2032
  • Table 48 : East Asia Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Application, 2017–2032
  • Table 49 : East Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017–2032
  • Table 50 : East Asia Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Technique, 2017–2032
  • Table 51 : South Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Country, 2017–2032
  • Table 52 : South Asia Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Country, 2017–2032
  • Table 53 : South Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017–2032
  • Table 54 : South Asia Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Product, 2017–2032
  • Table 55 : South Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017–2032
  • Table 56 : South Asia Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By End User, 2017–2032
  • Table 57 : South Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017–2032
  • Table 58 : South Asia Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Application, 2017–2032
  • Table 59 : South Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017–2032
  • Table 60 : South Asia Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Technique, 2017–2032
  • Table 61 : Oceania Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Country, 2017–2032
  • Table 62 : Oceania Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Country, 2017–2032
  • Table 63 : Oceania Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017–2032
  • Table 64 : Oceania Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Product, 2017–2032
  • Table 65 : Oceania Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017–2032
  • Table 66 : Oceania Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By End User, 2017–2032
  • Table 67 : Oceania Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017–2032
  • Table 68 : Oceania Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Application, 2017–2032
  • Table 69 : Oceania Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017–2032
  • Table 70 : Oceania Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Technique, 2017–2032
  • Table 71 : MEA Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Country, 2017–2032
  • Table 72 : MEA Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Country, 2017–2032
  • Table 73 : MEA Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017–2032
  • Table 74 : MEA Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Product, 2017–2032
  • Table 75 : MEA Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017–2032
  • Table 76 : MEA Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By End User, 2017–2032
  • Table 77 : MEA Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017–2032
  • Table 78 : MEA Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Application, 2017–2032
  • Table 79 : MEA Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017–2032
  • Table 80 : MEA Molecular Diagnostics in Infectious Disease Testing Market Volume (‘000 Units) Forecast, By Technique, 2017–2032
  • Figure 1 : Global Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) and Volume (‘000 Units) Analysis, 2017-2021
  • Figure 2 : Global Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) and Volume (‘000 Units) Forecast 2022-2032
  • Figure 3 : Global Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis, 2017-2021
  • Figure 4 : Global Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Forecast, 2022-2032
  • Figure 5 : Global Molecular Diagnostics in Infectious Disease Testing Absolute $ Opportunity (US$ Mn) 2022-2032
  • Figure 6 : Global Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Product, 2017-2032
  • Figure 7 : Global Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by Product, 2017-2032
  • Figure 8 : Global Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Product, 2022–2032
  • Figure 9 : Global Molecular Diagnostics in Infectious Disease Testing Attractiveness by Product, 2022-2032
  • Figure 10 : Global Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by End User, 2017-2032
  • Figure 11 : Global Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by End User, 2017-2032
  • Figure 12 : Global Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By End User, 2022–2032
  • Figure 13 : Global Molecular Diagnostics in Infectious Disease Testing Attractiveness by End User, 2022-2032
  • Figure 14 : Global Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Application, 2017-2032
  • Figure 15 : Global Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by Application, 2017-2032
  • Figure 16 : Global Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Application, 2022–2032
  • Figure 17 : Global Molecular Diagnostics in Infectious Disease Testing Attractiveness by Application, 2022-2032
  • Figure 18 : Global Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Technique, 2017-2032
  • Figure 19 : Global Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by Technique, 2017-2032
  • Figure 20 : Global Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Technique, 2022–2032
  • Figure 21 : Global Molecular Diagnostics in Infectious Disease Testing Attractiveness by Technique, 2022-2032
  • Figure 22 : Global Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Region, 2017-2032
  • Figure 23 : Global Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by Region, 2017-2032
  • Figure 24 : Global Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Region, 2022–2032
  • Figure 25 : Global Molecular Diagnostics in Infectious Disease Testing Attractiveness by Region, 2022-2032
  • Figure 26 : North America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Country, 2017-2032
  • Figure 27 : North America Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by Country, 2017-2032
  • Figure 28 : North America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Country, 2022–2032
  • Figure 29 : North America Molecular Diagnostics in Infectious Disease Testing Attractiveness by Country, 2022-2032
  • Figure 30 : North America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Product, 2017-2032
  • Figure 31 : North America Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by Product, 2017-2032
  • Figure 32 : North America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Product, 2022–2032
  • Figure 33 : North America Molecular Diagnostics in Infectious Disease Testing Attractiveness by Product, 2022-2032
  • Figure 34 : North America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by End User, 2017-2032
  • Figure 35 : North America Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by End User, 2017-2032
  • Figure 36 : North America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By End User, 2022–2032
  • Figure 37 : North America Molecular Diagnostics in Infectious Disease Testing Attractiveness by End User, 2022-2032
  • Figure 38 : North America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Application, 2017-2032
  • Figure 39 : North America Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by Application, 2017-2032
  • Figure 40 : North America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Application, 2022–2032
  • Figure 41 : North America Molecular Diagnostics in Infectious Disease Testing Attractiveness by Application, 2022-2032
  • Figure 42 : North America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Technique, 2017-2032
  • Figure 43 : North America Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by Technique, 2017-2032
  • Figure 44 : North America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Technique, 2022–2032
  • Figure 45 : North America Molecular Diagnostics in Infectious Disease Testing Attractiveness by Technique, 2022-2032
  • Figure 46 : Latin America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Country, 2017-2032
  • Figure 47 : Latin America Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by Country, 2017-2032
  • Figure 48 : Latin America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Country, 2022–2032
  • Figure 49 : Latin America Molecular Diagnostics in Infectious Disease Testing Attractiveness by Country, 2022-2032
  • Figure 50 : Latin America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Product, 2017-2032
  • Figure 51 : Latin America Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by Product, 2017-2032
  • Figure 52 : Latin America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Product, 2022–2032
  • Figure 53 : Latin America Molecular Diagnostics in Infectious Disease Testing Attractiveness by Product, 2022-2032
  • Figure 54 : Latin America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by End User, 2017-2032
  • Figure 55 : Latin America Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by End User, 2017-2032
  • Figure 56 : Latin America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By End User, 2022–2032
  • Figure 57 : Latin America Molecular Diagnostics in Infectious Disease Testing Attractiveness by End User, 2022-2032
  • Figure 58 : North America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Technique, 2017-2032
  • Figure 59 : North America Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by Technique, 2017-2032
  • Figure 60 : North America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Technique, 2022–2032
  • Figure 61 : North America Molecular Diagnostics in Infectious Disease Testing Attractiveness by Technique, 2022-2032
  • Figure 62 : Latin America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Country, 2017-2032
  • Figure 63 : Latin America Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by Technique, 2017-2032
  • Figure 64 : Latin America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Technique, 2022–2032
  • Figure 65 : Latin America Molecular Diagnostics in Infectious Disease Testing Attractiveness by Technique, 2022-2032
  • Figure 66 : Europe Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Country, 2017-2032
  • Figure 67 : Europe Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by Country, 2017-2032
  • Figure 68 : Europe Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Country, 2022–2032
  • Figure 69 : Europe Molecular Diagnostics in Infectious Disease Testing Attractiveness by Country, 2022-2032
  • Figure 70 : Europe Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Product, 2017-2032
  • Figure 71 : Europe Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by Product, 2017-2032
  • Figure 72 : Europe Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Product, 2022–2032
  • Figure 73 : Europe Molecular Diagnostics in Infectious Disease Testing Attractiveness by Product, 2022-2032
  • Figure 74 : Europe Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by End User, 2017-2032
  • Figure 75 : Europe Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by End User, 2017-2032
  • Figure 76 : Europe Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By End User, 2022–2032
  • Figure 77 : Europe Molecular Diagnostics in Infectious Disease Testing Attractiveness by End User, 2022-2032
  • Figure 78 : Europe Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Application, 2017-2032
  • Figure 79 : Europe Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by Application, 2017-2032
  • Figure 80 : Europe Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Application, 2022–2032
  • Figure 81 : Europe Molecular Diagnostics in Infectious Disease Testing Attractiveness by Application, 2022-2032
  • Figure 82 : Europe Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Technique, 2017-2032
  • Figure 83 : Europe Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by Technique, 2017-2032
  • Figure 84 : Europe Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Technique, 2022–2032
  • Figure 85 : Europe Molecular Diagnostics in Infectious Disease Testing Attractiveness by Technique, 2022-2032
  • Figure 86 : East Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Country, 2017-2032
  • Figure 87 : East Asia Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by Country, 2017-2032
  • Figure 88 : East Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Country, 2022–2032
  • Figure 89 : East Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by Country, 2022-2032
  • Figure 90 : East Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Product, 2017-2032
  • Figure 91 : East Asia Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by Product, 2017-2032
  • Figure 92 : East Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Product, 2022–2032
  • Figure 93 : East Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by Product, 2022-2032
  • Figure 94 : East Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by End User, 2017-2032
  • Figure 95 : East Asia Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by End User, 2017-2032
  • Figure 96 : East Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By End User, 2022–2032
  • Figure 97 : East Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by End User, 2022-2032
  • Figure 98 : East Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Application, 2017-2032
  • Figure 99 : East Asia Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by Application, 2017-2032
  • Figure 100 : East Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Application, 2022–2032
  • Figure 101 : East Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by Application, 2022-2032
  • Figure 102 : East Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Technique, 2017-2032
  • Figure 103 : East Asia Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by Technique, 2017-2032
  • Figure 104 : East Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Technique, 2022–2032
  • Figure 105 : East Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by Technique, 2022-2032
  • Figure 106 : South Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Country, 2017-2032
  • Figure 107 : South Asia Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by Country, 2017-2032
  • Figure 108 : South Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Country, 2022–2032
  • Figure 109 : South Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by Country, 2022-2032
  • Figure 110 : South Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Product, 2017-2032
  • Figure 111 : South Asia Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by Product, 2017-2032
  • Figure 112 : South Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Product, 2022–2032
  • Figure 113 : South Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by Product, 2022-2032
  • Figure 114 : South Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by End User, 2017-2032
  • Figure 115 : South Asia Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by End User, 2017-2032
  • Figure 116 : South Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By End User, 2022–2032
  • Figure 117 : South Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by End User, 2022-2032
  • Figure 118 : South Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Application, 2017-2032
  • Figure 119 : South Asia Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by Application, 2017-2032
  • Figure 120 : South Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Application, 2022–2032
  • Figure 121 : South Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by Application, 2022-2032
  • Figure 122 : South Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Technique, 2017-2032
  • Figure 123 : South Asia Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by Technique, 2017-2032
  • Figure 124 : South Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Technique, 2022–2032
  • Figure 125 : South Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by Technique, 2022-2032
  • Figure 126 : Oceania Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Country, 2017-2032
  • Figure 127 : Oceania Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by Country, 2017-2032
  • Figure 128 : Oceania Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Country, 2022–2032
  • Figure 129 : Oceania Molecular Diagnostics in Infectious Disease Testing Attractiveness by Country, 2022-2032
  • Figure 130 : Oceania Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Product, 2017-2032
  • Figure 131 : Oceania Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by Product, 2017-2032
  • Figure 132 : Oceania Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Product, 2022–2032
  • Figure 133 : Oceania Molecular Diagnostics in Infectious Disease Testing Attractiveness by Product, 2022-2032
  • Figure 134 : Oceania Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by End User, 2017-2032
  • Figure 135 : Oceania Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by End User, 2017-2032
  • Figure 136 : Oceania Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By End User, 2022–2032
  • Figure 137 : Oceania Molecular Diagnostics in Infectious Disease Testing Attractiveness by End User, 2022-2032
  • Figure 138 : Oceania Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Application, 2017-2032
  • Figure 139 : Oceania Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by Application, 2017-2032
  • Figure 140 : Oceania Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Application, 2022–2032
  • Figure 141 : Oceania Molecular Diagnostics in Infectious Disease Testing Attractiveness by Application, 2022-2032
  • Figure 142 : Oceania Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Technique, 2017-2032
  • Figure 143 : Oceania Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by Technique, 2017-2032
  • Figure 144 : Oceania Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Technique, 2022–2032
  • Figure 145 : Oceania Molecular Diagnostics in Infectious Disease Testing Attractiveness by Technique, 2022-2032
  • Figure 146 : MEA Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Country, 2017-2032
  • Figure 147 : MEA Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by Country, 2017-2032
  • Figure 148 : MEA Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Country, 2022–2032
  • Figure 149 : MEA Molecular Diagnostics in Infectious Disease Testing Attractiveness by Country, 2022-2032
  • Figure 150 : MEA Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Product, 2017-2032
  • Figure 151 : MEA Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by Product, 2017-2032
  • Figure 152 : MEA Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Product, 2022–2032
  • Figure 153 : MEA Molecular Diagnostics in Infectious Disease Testing Attractiveness by Product, 2022-2032
  • Figure 154 : MEA Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by End User, 2017-2032
  • Figure 155 : MEA Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by End User, 2017-2032
  • Figure 156 : MEA Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By End User, 2022–2032
  • Figure 157 : MEA Molecular Diagnostics in Infectious Disease Testing Attractiveness by End User, 2022-2032
  • Figure 158 : MEA Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Application, 2017-2032
  • Figure 159 : MEA Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by Application, 2017-2032
  • Figure 160 : MEA Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Application, 2022–2032
  • Figure 161 : MEA Molecular Diagnostics in Infectious Disease Testing Attractiveness by Application, 2022-2032
  • Figure 162 : MEA Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Technique, 2017-2032
  • Figure 163 : MEA Molecular Diagnostics in Infectious Disease Testing Volume (‘000 Units) Analysis by Technique, 2017-2032
  • Figure 164 : MEA Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Technique, 2022–2032
  • Figure 165 : MEA Molecular Diagnostics in Infectious Disease Testing Attractiveness by Technique, 2022-2032

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organization of all sizes.

Persistence Market Research
Price: $4900

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS